Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.
Also called NCT04734548
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 151 participants
- Sponsor
- aptaTargets S.L.
- Registry
-
NCT04734548
-
- Other papers using this trial's data
- Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France, Germany, Spain
- Registry status
- Completed
Technical summary
Registry record NCT04734548. Randomized; quadruple masking; primary purpose treatment. Start 2020-10-28 (actual); primary completion 2022-07-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke
- Condition
- Stroke
- Condition
- Acute Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- ApTOLL
- Intervention (Other)
- Placebo
- Lead sponsor
- aptaTargets S.L.
- Collaborator
- Ministry of Science and Innovation, Spain
- Collaborator
- Anagram
Record details
- Record id
cardio:ct-nct04734548- Content hash
407cc6a5c83200a62b7412d733e12ab96c733910a5f2830ef54b07b70d07e5b8